Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 20/20 | 1.00 |
| ▸ | HTR3A | P46098 | 2/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Izuforant SCHEMBL14828792 | 1.00 | HRH4 (1.00) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL27188718 | 1.00 | HRH4 (1.00) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL31539860 | 0.99 | HRH4 (0.98) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL27075814 | 0.99 | HRH4 (0.98) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL14828927 | 0.99 | HRH4 (0.98) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL14828944 | 0.99 | HRH4 (0.98) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL14829135 | 0.99 | HRH4 (0.98) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL14829381 | 0.94 | HRH4 (0.88) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL14828833 | 0.94 | HRH4 (0.88) | HRH4HTR3AHRH3 | |
| Izuforant SCHEMBL14829049 | 0.94 | HRH4 (0.88) | HRH4HTR3AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | disclosed |